Drug-Eluting Stents “Deliver Heartburn”-Reference-Cited by-同舟云学术

Drug-Eluting Stents “Deliver Heartburn”

Published:2007-06-12 Issue:23 Volume:115 Page:2990-2994
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Krucoff Mitchell W.¹,Boam Ashley¹,Schultz Daniel G.¹

Affiliation:

1. From the Duke University Medical Center/Duke Clinical Research Institute, Durham, NC (M.W.K.), and Center for Devices and Radiologic Health, United States Food and Drug Administration, Rockville, Md (A.B., D.G.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Thrombosis in Coronary Drug-Eluting Stents

2. Stent Thrombosis Redux — The FDA Perspective

3. Problems with Drug-Eluting Coronary Stents — The FDA Perspective

4. Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents

5. Late Ischemic Events After Clopidogrel Cessation Following Drug-Eluting Stenting

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Device Innovation: Prospective Solutions for an Ecosystem in Crisis;JACC: Cardiovascular Interventions;2012-07

2. 薬剤溶出性ステントのポリマーは血管における組織因子の発現を上昇させ,内皮機能障害を引き起こす(2.急性冠症候群発症:粥腫破綻後の血栓形成の分子機構,<特集II>第74回日本循環器学会学術集会);Journal of JCS Cardiologists;2011-04-25

3. Differences in the approval process for interventional devices in Europe and USA: IN MEDIO STAT VIRTUS;EuroIntervention;2011-03

4. Parylene-Encapsulated Copolymeric Membranes as Localized and Sustained Drug Delivery Platforms;Annals of Biomedical Engineering;2009-03-07

5. Outcomes Following Coronary Stenting in the Era of Bare-Metal vs the Era of Drug-Eluting Stents;JAMA;2008-06-25